logo
logo

Precision Medicine Company Adyn Raises $2.5M Seed Funding For Personalized Birth Control

Apr 19, 2021•about 4 years ago

Amount Raised

$2.5 Million

Round Type

seed

Seattle

Description

adyn, a precision medicine company, announced today that it has closed a $2.5 million seed round of funding. The round was co-led by Lux Capital and M13 with participation from Civilization Ventures, Concrete Rose Capital, Y Combinator, Madrona Pioneer Fund, Ascend VC, and angel investors including Anne Wojcicki of 23andMe, Nish Bhat of Color Genomics, Qasar Younis of Applied Intuition, and Ashley Mayer of Glossier.

Company Information

Company

Adyn

Location

Seattle, Washington, United States

About

adyn is a precision medicine company that is making scientific discovery more inclusive so everyone can live their healthiest life. Founded in 2019, adyn provides medically actionable scientific insights and empowers individuals to proactively optimize their health—from birth control, to fertility, and beyond. For more information, follow adyn on Twitter, LinkedIn and Instagram. Please visit https://www.adyn.com.